{
    "clinical_study": {
        "@rank": "72044", 
        "arm_group": [
            {
                "arm_group_label": "Vaginal DHEA", 
                "arm_group_type": "Experimental", 
                "description": "Vaginal DHEA 0.5%(6.5mg)inserted nightly"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "There does not appear to be a consensus regarding the treatment of vaginal dryness in women\n      who have a contraindication to the use of estrogen products. DHEA, when used locally, may\n      improve the symptoms of vaginal dryness due to its chemical properties."
        }, 
        "brief_title": "Vaginal DHEA for Women After Breast Cancer", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Vaginal Dryness", 
            "Breast Cancer", 
            "Urinary Incontinence", 
            "Quality of Life", 
            "Sexual Satisfaction"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Urinary Incontinence"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  women post menopausal aged 35-55, suffering from vaginal dryness, secondary to\n             chemotherapy for breast cancer, within 5 years of diagnosis. Follicle Stimulating\n             Hormone and Estradiol levels in the post menopausal range are needed.\n\n        Exclusion Criteria:\n\n          -  women using products to alleviate vaginal dryness.\n\n          -  women taking medication for urinary incontinence\n\n          -  women not sexually active, for other reasons."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 7, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01724242", 
            "org_study_id": "DHEA-HMO-CTIL"
        }, 
        "intervention": {
            "arm_group_label": "Vaginal DHEA", 
            "intervention_name": "Vaginal DHEA", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Dehydroepiandrosterone"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Vaginal dryness", 
            "Breast Cancer", 
            "Urinary Incontinence", 
            "Quality of Life", 
            "Sexual Satisfaction"
        ], 
        "lastchanged_date": "November 7, 2012", 
        "location": {
            "contact": {
                "email": "lhadas@hadassah.org.il", 
                "last_name": "Hadas Lemberg, PhD", 
                "phone": "00 972 2 6777572"
            }, 
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel"
                }, 
                "name": "Hadassah Medical Organization"
            }, 
            "investigator": {
                "last_name": "Drorith Hochner-Celnikier, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Vaginal DHEA to Ease Vaginal Dryness in Women With a Contraindication to Estrogen Therapy", 
        "overall_contact": {
            "email": "hochner@hadassah.org.il", 
            "last_name": "Drorith Hochner-Celnikier, MD", 
            "phone": "00 972 2 5844400"
        }, 
        "overall_official": {
            "affiliation": "Hadassah Medical Organization", 
            "last_name": "Drorith Hochner-Celnikier, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "improvement in vaginal dryness", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01724242"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "improvement in urinary incontinence", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "improvement in sexual satisfaction", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "Hadassah Medical Organization", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hadassah Medical Organization", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}